Dose-response in stereotactic irradiation of lung tumors.

[1]  R. Arriagada,et al.  Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. , 1991, Journal of the National Cancer Institute.

[2]  I. Lax,et al.  Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. , 1994, Acta oncologica.

[3]  I. Lax,et al.  Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.

[4]  I. Lax,et al.  Extracranial Stereotactic Radiosurgery of Localized Targets , 1998 .

[5]  G. Sibley.  Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma , 1998, Cancer.

[6]  I. Lax,et al.  Radiosurgery for Tumors in the Body: Clinical Experience Using a New Method , 1998 .

[7]  A Harvey,et al.  Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  R K Ten Haken,et al.  Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.

[9]  K Nakagawa,et al.  Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. , 2000, International journal of radiation oncology, biology, physics.

[10]  U Oppitz,et al.  Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  Michael Flentje,et al.  Stereotactic Radiotherapy of Targets in the Lung and Liver , 2001, Strahlentherapie und Onkologie.

[12]  J. Wong,et al.  Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.

[13]  Kurt Baier,et al.  Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.

[14]  B. Jeremic,et al.  Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.

[15]  Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformity. , 2002, Zeitschrift fur medizinische Physik.

[16]  Y. Shibamoto,et al.  Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. , 2001, International journal of radiation oncology, biology, physics.

[17]  Takashi Aruga,et al.  Stereotactic single high dose irradiation of lung tumors under respiratory gating. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  Stephanie Frost,et al.  Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. , 2003, Chest.

[19]  Michael Flentje,et al.  Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Angelika Hoess,et al.  Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). , 2003, International journal of radiation oncology, biology, physics.

[21]  Shinichi Shimizu,et al.  Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. , 2003, International journal of radiation oncology, biology, physics.

[22]  L. Boersma,et al.  First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  Seung Do Ahn,et al.  Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. , 2003, Lung cancer.

[24]  Michael Flentje,et al.  Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. , 2004, International journal of radiation oncology, biology, physics.

[25]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[26]  Adaptive radiotherapy in stereotactic radiotherapy of extracranial targets: Integration of CT-verification on the treatment couch using a dedicated software to calculate the current stereotactic coordinate including evaluation of breathing mobility , 2004 .

[27]  Jeffrey Bradley,et al.  Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[28]  Thomas Krieger,et al.  Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. , 2005, International journal of radiation oncology, biology, physics.

[29]  Branislav Jeremic,et al.  Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. , 2005, Lung cancer.